Bulk Inquiry
SU 5402
- Soluble in 0.1N NaOH(aq) and DMSO
- MF: C17H16N2O3
- MW: 296.32
Description
SU 5402 is a small-molecule fibroblast growth factor receptor (FGFR) inhibitor used to suppress FGF receptor signaling in cellular and developmental models.
FGF/FGFR signaling controls proliferation, differentiation, survival and embryonic patterning. SU 5402 is widely used to dissect FGFR-dependent signaling and is included in stem cell inhibitor combinations that help maintain mouse embryonic stem cell self-renewal.
Key Features
- Inhibits FGFR-mediated signaling
- Used in FGF-dependent developmental and stem cell models
- Supports study of receptor tyrosine kinase pathway inhibition
- Part of established stem cell inhibitor set protocols
Applications
- FGF/FGFR pathway research
- Stem cell self-renewal and differentiation studies
- Developmental biology assays
- RTK signaling and pathway crosstalk studies
Promotion: SU 5402 is also part of inhibitor sets:
| Stem Cell 3i inhibitor Set (Axon 2129) |
| Stem Cell CSD inhibitor Set (Axon 5006) |
| Stem Cell 5i inhibitor Set (Axon 5007) |
More Information
| Parent CAS No. | 215543-92-3 |
|---|---|
| Chemical Name | 3-(4-methyl-2-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid |
| SMILES | C1C=C2NC(=O)/C(=CC3=C(CCC(O)=O)C(C)=CN3)/C2=CC=1 |
| MFCD | MFCD08235144 |
| InChi | InChI=1S/C17H16N2O3/c1-10-9-18-15(11(10)6-7-16(20)21)8-13-12-4-2-3-5-14(12)19-17(13)22/h2-5,8-9,18H,6-7H2,1H3,(H,19,22)(H,20,21)/b13-8- |
| InChiKey | JNDVEAXZWJIOKB-JYRVWZFOSA-N |
| CID | 5289418 |
| Short Description | FGFR inhibitor |
References
- EK Grand et al. Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074. Leukemia 2004, 18, 962–966.
- Y Tanaka et al. FGF-induced vesicular release of Sonic hedgehog and retinoic acid in leftward nodal flow is critical for left-right determination. Nature 2005, 435(7039), 172-177.
- JL Paterson et al. Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma. Br. J. Haematol. 2004, 124(5), 595-603.
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1128 | Erlotinib hydrochloride |
From $77.00 |
| 1393 | Gefitinib |
From $77.00 |
| 1395 | Lapatinib ditosylate |
From $88.00 |
| 1398 | Sunitinib malate |
From $88.00 |
| 1411 | Vandetanib |
From $55.00 |
| 1414 | AG 013736 |
From $55.00 |
| 1419 | AB 1010 |
From $77.00 |
| 1420 | Pazopanib hydrochloride |
From $66.00 |
| 1433 | CI 1033 |
From $66.00 |
| 1461 | Cediranib |
From $77.00 |
| 1506 | WZ 4002 |
From $77.00 |
| 1526 | Neratinib |
From $88.00 |
| 1544 | BIBW 2992 |
From $55.00 |
| 1547 | OSI 930 |
From $99.00 |
| 1632 | OSI 420 |
From $99.00 |
| 1637 | Vatalanib |
From $82.50 |
| 1638 | ABT 869 |
From $88.00 |
| 1653 | AEE 788 |
From $88.00 |
| 1662 | CP 547632 |
From $77.00 |
| 1665 | Pelitinib |
From $99.00 |
| 1673 | PD173074 |
From $82.50 |
| 1678 | Regorafenib |
From $77.00 |
| 1717 | Tivozanib |
From $88.00 |
| 1760 | EGFR Inhibitor [879127-07-8] |
From $132.00 |
